| Subject: | [youthgas] Participants sought for hep C medical trial (Sydney) | | Date: | Monday, February 18, 2008 08:47:17 (+1100) | | From: | paulh <paulh @..............au>
|
Do you have clients with chronic hep C?
Have any of them failed to respond to standard treatment?
If the answer is yes to these questions, then you may be interested in
helping promote recruitment to a trial that is studying a new
combination treatment.
Trial participants will be under specialist supervision and will incur
no out-of-pocket expenses. The trial is carried out in conjunction with
people's own doctors.
Trialling: Chenodeoxycholic acid / Bezafibrate
Investigating: The use of the lipid metabolism regulators to interfere
with a component of the hep C viral replication pathway. Bezafibrate and
chenodeoxycholic acid (CDCA) are currently individually marketed, in
some countries, for regulation of lipid metabolism. Preliminary
investigations particularly by Kurihara et al (2001), Fujita et al
(2006) and Hirata et al (2002) have shown that each of these drugs
exhibit potential activity against HCV infection.
Preliminary work at the Centre for Digestive Diseases indicates greatly
improved liver function in a very short period of time with almost no
adverse effects.
Contact: For more information about the trial, or in referring clients,
please contact..
The Research Department
Centre for Digestive Diseases
Ph: 02 9713 4011 (press option '3')
Email: clinical_trials@cdd.com
Posted by
Paul Harvey
Coordinator - Information & Resources
Hepatitis C Council of NSW Inc
PO Box 432, Darlinghurst NSW 1300 Sydney
Phone +61 2 9332 1853
Fax +61 2 9332 1730
www.hepatitisc.org.au
Please Note: "This message is intended only for the addressee named and may
contain confidential information.
If you are not the intended recipient, or have received this transmission in
error, please delete it and notify the sender immediately.
You must not disclose or use the information herein unless we authorise you to
do so.
The views expressed are those of the individual sender, and are not necessarily
the views of the Hepatitis C Council of NSW Inc.
The Hepatitis C Council of NSW Inc Privacy Policy adheres to the Guidelines on
Privacy in the Private Health Sector
and is available on our website, www.hepatitisc.org.au
This note also confirms that this e-mail message has been virus scanned and
although no computer viruses were detected,
the Hepatitis C Council of NSW Inc accepts no liability for any consequential
damage resulting from e-mails containing any computer viruses."
|
Participants sough
Reply to this message